Positron emission tomography (PET) is nowadays the ultimate diagnostic tool to detect tumours and identify their metabolic status.
Yet, research in the field of biomedical imaging has the strongest growth at the Université de Sherbrooke.
Very early in his career, Professor Roger Lecomte advocated for a new approach to improve the resolution of images obtained from positron emission tomography.
Today, teams are working on developing PET imaging devices to study brain biochemistry with a resolution twice as high as anything currently in existence. These technological advances will contribute to better understanding the underlying causes of the neurodegenerative diseases increasingly affecting our society. Research in biomedical imaging is directly contributing to discovering preventive or curative treatments.
Principal Investigator : Roger Lecomte